Fischer MA - Search Results

1

Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.

Franklin JM, Choudhry NK, Uscher-Pines L, Brill G, Matlin OS, Fischer MA, Schneeweiss S, Avorn J, Brennan TA, Shrank WH. Franklin JM, et al. Among authors: fischer ma. Am J Public Health. 2014 Jun;104(6):1052-8. doi: 10.2105/AJPH.2013.301762. Epub 2014 Apr 17. Am J Public Health. 2014. PMID: 24825206 Free PMC article.

2

Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

Fischer MA, Avorn J. Fischer MA, et al. Health Serv Res. 2003 Aug;38(4):1051-63. doi: 10.1111/1475-6773.00162. Health Serv Res. 2003. PMID: 12968816 Free PMC article.

3

Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.

Fischer MA, Solomon DH, Teich JM, Avorn J. Fischer MA, et al. Arch Intern Med. 2003 Nov 24;163(21):2585-9. doi: 10.1001/archinte.163.21.2585. Arch Intern Med. 2003. PMID: 14638558

4

Economic implications of evidence-based prescribing for hypertension: can better care cost less?

Fischer MA, Avorn J. Fischer MA, et al. JAMA. 2004 Apr 21;291(15):1850-6. doi: 10.1001/jama.291.15.1850. JAMA. 2004. PMID: 15100203

5

Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.

Fischer MA, Avorn J. Fischer MA, et al. Pharmacoepidemiol Drug Saf. 2004 Apr;13(4):207-14. doi: 10.1002/pds.872. Pharmacoepidemiol Drug Saf. 2004. PMID: 15255087

6

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.

Fischer MA, Schneeweiss S, Avorn J, Solomon DH. Fischer MA, et al. N Engl J Med. 2004 Nov 18;351(21):2187-94. doi: 10.1056/NEJMsa042770. N Engl J Med. 2004. PMID: 15548779 Free article.

7

An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre.

Fischer MA, Lilly CM, Churchill WW, Baden LR, Avorn J. Fischer MA, et al. Drug Saf. 2004;27(15):1253-61. doi: 10.2165/00002018-200427150-00008. Drug Saf. 2004. PMID: 15588120

8

Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives.

Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Wang PS, et al. Among authors: fischer ma. Hypertension. 2005 Aug;46(2):273-9. doi: 10.1161/01.HYP.0000172753.96583.e1. Epub 2005 Jun 27. Hypertension. 2005. PMID: 15983239

9

The hepatotoxicity of antifungal medications in bone marrow transplant recipients.

Fischer MA, Winkelmayer WC, Rubin RH, Avorn J. Fischer MA, et al. Clin Infect Dis. 2005 Aug 1;41(3):301-7. doi: 10.1086/431586. Epub 2005 Jun 24. Clin Infect Dis. 2005. PMID: 16007524

10

Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.

Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Winkelmayer WC, et al. Among authors: fischer ma. Am J Kidney Dis. 2005 Dec;46(6):1080-7. doi: 10.1053/j.ajkd.2005.08.018. Am J Kidney Dis. 2005. PMID: 16310574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters